Ceapro Inc. (CVE:CZO – Get Free Report)’s share price dropped 11.8% on Tuesday. The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Trading Down 11.8%
The stock has a market capitalization of C$688,880.00, a price-to-earnings ratio of -2.83 and a beta of 1.38. The company has a debt-to-equity ratio of 8.07, a quick ratio of 18.88 and a current ratio of 8.54. The business has a 50-day moving average of C$0.22 and a 200-day moving average of C$0.23.
Ceapro Company Profile
Ceapro Inc., a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Further Reading
- Five stocks we like better than Ceapro
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
